CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$45.15 -4.89 (-9.77%)
At close: Nov 10, 2026 · 4:00 PM EST

CRISPR Therapeutics AG (CRSP) Other financing activities (as filed) (2016 - 2026)

Updated

CRISPR Therapeutics AG (CRSP) recorded Other financing activities (as filed) of -$1.12 million in Q2 2026.

Analysis

CRISPR Therapeutics AG (CRSP) Other financing activities (as filed) (2016 - 2026) Analysis & Trends

For FY2025, CRISPR Therapeutics AG reported Other financing activities (as filed) of -$7.8 million.

  • Across earlier years, Other financing activities (as filed) came in at -$300,000 in FY2024, -$400,000 in FY2023, -$2.4 million in FY2022 and -$3.1 million in FY2021.
  • The Q2 2026 figure is the highest quarterly Other financing activities (as filed) since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 CRISPR Therapeutics AG 4.65 Bn -4.41 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.12 Mn
Mar 31, 2026 -13.53 Mn
Dec 31, 2025 -1.00 Mn
Sep 30, 2025 -6.80 Mn
Dec 31, 2024 2.60 Mn
Mar 31, 2024 -2.90 Mn
Dec 31, 2023 2.00 Mn
Mar 31, 2023 -2.40 Mn
Mar 31, 2022 -2.40 Mn
Dec 31, 2021 -700,000.00
Mar 31, 2021 -2.40 Mn
Dec 31, 2016 2.68 Mn
API Access

CRISPR Therapeutics AG Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CRSP&period=max&api_key=YOUR_API_KEY